These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 894674)

  • 41. Influence of cadmium ions on contractile response of isolated aortas to stimulatory agents.
    Toda N
    Am J Physiol; 1973 Aug; 225(2):350-5. PubMed ID: 4352898
    [No Abstract]   [Full Text] [Related]  

  • 42. The pressor and myotropic effects and the antagonistic properties of several analogues of angiotensin II.
    Regoli D; Park WK
    Can J Physiol Pharmacol; 1972 Feb; 50(2):99-112. PubMed ID: 4336727
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of prolactin on the responses of rat aortic and arteriolar smooth-muscle preparations to noradrenaline and angiotensin.
    Manku MS; Nassar BA; Horrobin DF
    Lancet; 1973 Nov; 302(7836):991-4. PubMed ID: 4127278
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacology of angiotensin.
    Regoli D; Park WK; Rioux F
    Pharmacol Rev; 1974 Jun; 26(2):69-123. PubMed ID: 4371235
    [No Abstract]   [Full Text] [Related]  

  • 45. Angiotensin II antagonism. Structure-activity relationships of 8-substituted angiotensin II analogs.
    Fessler DC; Slipos F; Denning GS; Pals DT; Masucci FD
    J Med Chem; 1972 Oct; 15(10):1015-6. PubMed ID: 4341746
    [No Abstract]   [Full Text] [Related]  

  • 46. An angiotensin II antagonist with strongly prolonged action.
    Holck M; Bossé R; Fischli W; Gerold H; Escher E
    Biochem Biophys Res Commun; 1989 May; 160(3):1350-6. PubMed ID: 2730646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New angiotensin analogues: 8-(L-alpha-methyl-3,4-dihydroxyphenylalanine)-angiotensin II.
    Arakawa K; Hirata M; Watanabe K; Kuga H; Hattori E
    Chem Pharm Bull (Tokyo); 1979 Apr; 27(3):1030-3. PubMed ID: 476857
    [No Abstract]   [Full Text] [Related]  

  • 48. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on position 1 of angiotensin II: effects on affinity and duration of action from alkyl amide substitution.
    Cordopatis P; Theodoropoulos D; Guillemette G; Escher E
    J Med Chem; 1981 Feb; 24(2):209-11. PubMed ID: 7205889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific and irreversible block of the myotropic action of angiotensin II.
    Escher EH; Nguyen TM; Guillemette G; Regoli DC
    Nature; 1978 Sep; 275(5676):145-6. PubMed ID: 211425
    [No Abstract]   [Full Text] [Related]  

  • 51. Differential effects of substrate depletion on drug-induced contractions of rabbit aorta.
    Altura BM; Altura BT
    Am J Physiol; 1970 Dec; 219(6):1698-705. PubMed ID: 4320911
    [No Abstract]   [Full Text] [Related]  

  • 52. Competative antagonism of 8-ala-angiotensin II to angiotensins I and II on isolated rabbit aorta and rat colon.
    Turker RK; Yamamoto MY; Khairallah PA; Bumpus FM
    Eur J Pharmacol; 1971; 15(3):285-91. PubMed ID: 4334171
    [No Abstract]   [Full Text] [Related]  

  • 53. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
    Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
    J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelium enhances tachyphylaxis to angiotensins II and III in rat aorta.
    Gruetter CA; Ryan ET; Schoepp DD
    Eur J Pharmacol; 1987 Nov; 143(1):139-42. PubMed ID: 3691648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A specific competitive antagonist of the vascular action of angiotensin. II.
    Pals DT; Masucci FD; Sipos F; Denning GS
    Circ Res; 1971 Dec; 29(6):664-72. PubMed ID: 4399642
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of lidoflazine on norepinephrine, angiotensin and serotonin responses in isolated smooth muscle preparations.
    Türker RK; Kayaalp SO
    Experientia; 1967 Aug; 23(8):647. PubMed ID: 4293123
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
    Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
    J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the effects of angiotensin II and heptapeptide on smooth muscle (vascular and uterine).
    Moore AF; HAll MM; Khairallah PA
    Eur J Pharmacol; 1976 Sep; 39(1):101-7. PubMed ID: 183963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of synthetic angiotensin on the intestine and search for its antagonists].
    Irsakaeva AA; Kudrin AN
    Farmakol Toksikol; 1968; 31(4):447-50. PubMed ID: 4301580
    [No Abstract]   [Full Text] [Related]  

  • 60. A potent competitive antagonist of angiotensin II.
    Yamamoto M; Türker RK; Khairallah PA; Bumpus FM
    Eur J Pharmacol; 1972 May; 18(3):316-22. PubMed ID: 4338477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.